BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1548056)

  • 1. Lymphoproliferative activity of Pseudomonas exotoxin A is dependent on intracellular processing and is associated with the carboxyl-terminal portion.
    Legaard PK; LeGrand RD; Misfeldt ML
    Infect Immun; 1992 Apr; 60(4):1273-8. PubMed ID: 1548056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The superantigen Pseudomonas exotoxin A requires additional functions from accessory cells for T lymphocyte proliferation.
    Legaard PK; LeGrand RD; Misfeldt ML
    Cell Immunol; 1991 Jul; 135(2):372-82. PubMed ID: 1903675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective activation of murine V beta 8.2 bearing T cells by Pseudomonas exotoxin A.
    Dixon DM; LeGrand RD; Misfeldt ML
    Cell Immunol; 1992 Nov; 145(1):91-9. PubMed ID: 1358461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of interleukin-1 from murine peritoneal macrophages by Pseudomonas aeruginosa exotoxin A.
    Misfeldt ML; Legaard PK; Howell SE; Fornella MH; LeGrand RD
    Infect Immun; 1990 Apr; 58(4):978-82. PubMed ID: 2108093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of monoclonal antibody B7, which neutralizes the cytotoxicity of Pseudomonas aeruginosa exotoxin A.
    Shang HF; Yeh ML; Lin CP; Hwang J
    Clin Diagn Lab Immunol; 1996 Nov; 3(6):727-32. PubMed ID: 8914766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the carboxyl-terminal amino acids important for the ADP-ribosylation activity of Pseudomonas exotoxin A.
    Chow JT; Chen MS; Wu HC; Hwang J
    J Biol Chem; 1989 Nov; 264(31):18818-23. PubMed ID: 2553721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity.
    Chaudhary VK; Jinno Y; FitzGerald D; Pastan I
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):308-12. PubMed ID: 2104981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant form of Pseudomonas exotoxin directed at the epidermal growth factor receptor that is cytotoxic without requiring proteolytic processing.
    Theuer CP; FitzGerald D; Pastan I
    J Biol Chem; 1992 Aug; 267(24):16872-7. PubMed ID: 1512230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL.
    Seetharam S; Chaudhary VK; FitzGerald D; Pastan I
    J Biol Chem; 1991 Sep; 266(26):17376-81. PubMed ID: 1910044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of Pseudomonas exotoxin. Identification of a rate-limiting step.
    Zdanovsky AG; Chiron M; Pastan I; FitzGerald DJ
    J Biol Chem; 1993 Oct; 268(29):21791-9. PubMed ID: 8408034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of murine immune response by Pseudomonas aeruginosa exotoxin A.
    Holt PS; Misfeldt ML
    Infect Immun; 1984 Jul; 45(1):227-33. PubMed ID: 6429047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nontoxic Pseudomonas exotoxin A induces active immunity and passive protective antibody against Pseudomonas exotoxin A intoxication.
    Chen TY; Lin CP; Loa CC; Chen TL; Shang HF; Hwang J; Hui CF
    J Biomed Sci; 1999; 6(5):357-63. PubMed ID: 10494043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T-cell mediated tumor protection by Pseudomonas exotoxin fused to ovalbumin in C57BL/6 mice.
    Becerra JC; Arthur JF; Landucci GR; Forthal DN; Theuer CP
    Surgery; 2003 Apr; 133(4):404-10. PubMed ID: 12717358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Pseudomonas exotoxin activation and conformational changes by using monoclonal antibodies as probes.
    Ogata M; Pastan I; FitzGerald D
    Infect Immun; 1991 Jan; 59(1):407-14. PubMed ID: 1702764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma interferon, and IL-1 production in human leukocytes.
    Staugas RE; Harvey DP; Ferrante A; Nandoskar M; Allison AC
    Infect Immun; 1992 Aug; 60(8):3162-8. PubMed ID: 1639487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of immunization with DNA encoding Pseudomonas aeruginosa exotoxin A.
    Denis-Mize KS; Price BM; Baker NR; Galloway DR
    FEMS Immunol Med Microbiol; 2000 Feb; 27(2):147-54. PubMed ID: 10640610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol.
    Ogata M; Chaudhary VK; Pastan I; FitzGerald DJ
    J Biol Chem; 1990 Nov; 265(33):20678-85. PubMed ID: 2122978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases.
    Gordon VM; Klimpel KR; Arora N; Henderson MA; Leppla SH
    Infect Immun; 1995 Jan; 63(1):82-7. PubMed ID: 7806387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of pseudomonas exotoxin and diphtheria toxin by a furin-like enzyme prepared from beef liver.
    Chiron MF; Fryling CM; FitzGerald DJ
    J Biol Chem; 1994 Jul; 269(27):18167-76. PubMed ID: 8027078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice immunized with DNA encoding a modified Pseudomonas aeruginosa exotoxin A develop protective immunity against exotoxin intoxication.
    Shiau JW; Tang TK; Shih YL; Tai C; Sung YY; Huang JL; Yang HL
    Vaccine; 2000 Dec; 19(9-10):1106-12. PubMed ID: 11137245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.